US Patent Issued to Abbott Diabetes Care on July 28 for "Analyte sensors and sensing methods for detecting creatinine" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,693,255, issued on July 28, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Analyte sensors and sensing methods for detecting creatinine" was invented by Tianmei Ouyang (Fremont, Calif.), Benjamin J. Feldman (Berkeley, Calif.) and Hyun Cho (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Creatinine levels may be monitored as a measure of kidney function. Conventionally, blood and/or urine tests are used for this purpose. Analyte sensors capable of monitoring creatinine in vivo may comprise: a sensor tail comprising at least a first working electrode, a creatinine-responsive active area disposed upon a surface of the first w...